Silicon Valley Capital Partners’s Globus Medical GMED Stock Holding History

Silicon Valley Capital Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-550	Closed	-$39.9K	–	317
2025 Q1	$39.9K	Hold	550	–	–	0.01%	146
2024 Q4	$45.5K	Hold	550	–	–	0.01%	147
2024 Q3	$39.3K	Hold	550	–	–	0.01%	148
2024 Q2	$37.7K	Hold	550	–	–	0.01%	148
2024 Q1	$29.5K	Hold	550	–	–	﹤0.01%	151
2023 Q4	$29.3K	Buy	+550	New	+$26.8K	﹤0.01%	146

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Silicon Valley Capital Partners's GMED Position: Q2 2025 in Review

Silicon Valley Capital Partners sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 550 shares — an estimated $39.9K sold.

Silicon Valley Capital Partners first reported a position in GMED in Q4 2023 and held it in 6 quarters. The position peaked at $45.5K in Q4 2024. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

Silicon Valley Capital Partners reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
Silicon Valley Capital Partners sold 550 Globus Medical shares in Q2 2025, an estimated $39.9K.
Silicon Valley Capital Partners first reported a position in Globus Medical in Q4 2023 and held it in 6 quarters.
Silicon Valley Capital Partners's Globus Medical position peaked at $45.5K in Q4 2024.
480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Silicon Valley Capital Partners's 13F filing for Q2 2025, filed 11 Sep 2025.